Filing Details
- Accession Number:
- 0000950170-24-116075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-21 21:46:28
- Reporting Period:
- 2024-10-18
- Accepted Time:
- 2024-10-21 21:46:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531177 | Sight Sciences Inc. | SGHT | Surgical & Medical Instruments & Apparatus (3841) | 800625749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1565950 | Matthew Link | C/O Sight Sciences, Inc. 4040 Campbell Ave., Suite 100 Menlo Park CA 94025 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-10-18 | 20,487 | $5.98 | 685,381 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-10-21 | 21,831 | $5.61 | 663,550 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
- Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.86 to $6.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.50 to $5.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.